Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v3-EN
Language English English
Date Updated 2020-03-12 2020-03-12
Drug Identification Number 02413604 02413604
Brand name CARBAMAZEPINE CR CARBAMAZEPINE CR
Common or Proper name CARBAMAZEPINE CARBAMAZEPINE
Company Name PRO DOC LIMITEE PRO DOC LIMITEE
Ingredients CARBAMAZEPINE CARBAMAZEPINE
Strength(s) 400MG 400MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 100
ATC code N03AF N03AF
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-03-11 2020-03-11
Remaining supply date 2021-02-28 2021-02-28
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Discontinued- Cessation de vente Discontinued- Cessation de vente
Health Canada comments